Luchen Charlie Chaluma, Mwaba John, Ng'ombe Harriet, Alabi Peter Ibukun Oluwa, Simuyandi Michelo, Chilyabanyama Obvious N, Hatyoka Luiza Miyanda, Mubanga Cynthia, Bosomprah Samuel, Chilengi Roma, Chisenga Cleopatra Caroline
Enteric Diseases and Vaccine Research Unit, Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Amsterdam UMC, University of Amsterdam, Institute for Infection and Immunity, Amsterdam, the Netherlands.
PLoS One. 2021 Dec 2;16(12):e0260552. doi: 10.1371/journal.pone.0260552. eCollection 2021.
We set out to assess the impact of human immunodeficiency virus (HIV) and micronutrient deficiency as indicated by serum retinol levels on the immune responses to Oral Cholera Vaccine (Shanchol™) in a cohort of participants in Lukanga Swamps, Zambia. Cholera remains endemic in Zambia with vaccines being the only effective preventive measures. However, the effect of these vaccines on populations living with HIV has not been widely documented.
HIV testing and confirmation was done using the Alere Determine™ HIV-1/2 and Uni-Gold™ kits while vibriocidal antibody assay was applied for vaccine immunogenicity. Serum retinol analysis was assessed by Shimadzu Prominence HCT-2010 High Performance Liquid Chromatography (HPLC). The primary outcome was log transformed geometric mean titre.
From 47 participants screened for HIV, 51% (24) tested positive. There was a statistically significant reduction in Ogawa geometric mean ratio (GMR) by 67% (GMR = 0.33; 95% CI: -0.15, 0.76; p-value = 0.009) attributable to HIV positivity with a non-significant reduction in Inaba GMR by about 50% due to HIV positivity. When doubling of retinol levels modelled, GMR reduction against Ogawa were non-significant but that against Inaba resulted in a significant reduction in geometric mean titer (GMT) (GMT-0.33, C.I 0.16-0.66, p-value 0.002). At 1000copies/ml viral load cut off and 350 cells/μl CD4 counts, Ogawa GMT was two times higher 11.16 (95%CI: 8.20-15.19) versus 6.06 (95%CI: 4.04-9.10) in low viremia participants, and three times higher in above threshold CD4 count participants; 24.81 (95%CI: 18.94-32.50) versus 7.07 (95%CI: 5.22-9.58).
Our results show that while Shanchol™ is immunogenic in both HIV+/- individuals, HIV + participants responded poorly. Viral load and CD4 count affected vaccine immunogenicity. More research is required for detailed understanding of this in order to appropriately inform policy and practice.
我们旨在评估在赞比亚卢坎加沼泽地的一组参与者中,人类免疫缺陷病毒(HIV)以及血清视黄醇水平所表明的微量营养素缺乏对口服霍乱疫苗(Shanchol™)免疫反应的影响。霍乱在赞比亚仍然是地方病,疫苗是唯一有效的预防措施。然而,这些疫苗对HIV感染者的影响尚未得到广泛记录。
使用Alere Determine™ HIV-1/2和Uni-Gold™试剂盒进行HIV检测和确认,同时应用杀弧菌抗体检测来评估疫苗免疫原性。血清视黄醇分析通过岛津Prominence HCT-2010高效液相色谱法(HPLC)进行评估。主要结果是对数转换后的几何平均滴度。
在47名接受HIV筛查的参与者中,51%(24名)检测呈阳性。由于HIV阳性,小川型几何平均比值(GMR)有统计学意义地降低了67%(GMR = 0.33;95%置信区间:-0.15,0.76;p值 = 0.009);由于HIV阳性,稻叶型GMR降低了约50%但无统计学意义。当对视黄醇水平加倍进行建模时,针对小川型GMR的降低无统计学意义,但针对稻叶型GMR导致几何平均滴度(GMT)有显著降低(GMT - 0.33,置信区间0.16 - 0.66,p值0.002)。在病毒载量截断值为1000拷贝/毫升且CD4细胞计数为350个/微升时,低病毒血症参与者中小川型GMT高出两倍,分别为11.16(95%置信区间:8.20 - 15.19)和6.06(95%置信区间:4.04 - 9.10);在CD4计数高于阈值的参与者中高出三倍,分别为24.81(95%置信区间:18.94 - 32.50)和7.07(95%置信区间:5.22 - 9.58)。
我们的结果表明,虽然Shanchol™在HIV阳性和阴性个体中均具有免疫原性,但HIV阳性参与者的反应较差。病毒载量和CD4细胞计数影响疫苗免疫原性。为了适当地为政策和实践提供信息,需要进行更多研究以详细了解这一点。